Finance

Lists
1760:TPE
Panion & BF Biotech Inc
NT$58.30
-0.17%
(-0.10) 1D
Aug 18, 1:30:25 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1760...
Open
NT$58.40
High
NT$59.00
Low
NT$58.20
Mkt. cap
5.00B
Avg. vol.
208.94K
Volume
94.61K
Dividend
3.43%
Quarterly dividend
NT$0.50
Ex-dividend date
Jun 11, 2026
P/E ratio
23.43
52-wk high
NT$76.40
52-wk low
NT$57.90
EPS
NT$2.49
Shares outstanding
76.74M
No. of employees
321
Open
NT$58.40
High
NT$59.00
Low
NT$58.20
Mkt. cap
5.00B
Avg. vol.
208.94K
Volume
94.61K
Dividend
3.43%
Quarterly dividend
NT$0.50
Ex-dividend date
Jun 11, 2026
P/E ratio
23.43
52-wk high
NT$76.40
52-wk low
NT$57.90
EPS
NT$2.49
Shares outstanding
76.74M
No. of employees
321
About Panion & BF Biotech Inc
CEO-
Employees321
Founded1976
Headquarters-
SectorPharmaceutical industry
Websitepbf.com.tw
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
531.95M
546.14M
519.29M
511.84M
Cost of goods sold
231.66M
260.24M
249.91M
252.76M
Cost of revenue
231.66M
260.24M
249.91M
252.76M
Research and development expenses
45.90M
44.00M
41.03M
36.98M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
154.88M
168.49M
144.53M
160.16M
Operating expense
200.76M
213.55M
186.16M
197.21M
Total operating expenses
432.42M
473.79M
436.07M
449.97M
Operating income
99.52M
72.35M
83.22M
61.86M
Other non operating income
868.00K
2.88M
302.00K
3.02M
EBT including unusual items
104.58M
73.58M
80.60M
60.79M
EBT excluding unusual items
104.58M
73.49M
80.67M
60.79M
Income tax expense
29.23M
24.96M
28.86M
21.68M
Effective tax rate
27.95%
33.93%
35.80%
35.67%
Other operating expenses
-
-
-
-
Net income
75.35M
48.62M
51.74M
39.11M
Net profit margin
14.17%
8.90%
9.96%
7.64%
Earnings per share
-
-
-
-
Interest and investment income
349.00K
1.32M
146.00K
1.48M
Interest expense
-3.60M
-3.47M
-3.45M
-3.50M
Net interest expenses
-3.25M
-2.15M
-3.31M
-2.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
127.81M
100.99M
112.84M
100.03M
Gain or loss from assets sale
-
125.00K
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps